Twist Bioscience (TWST) Assets Average (2018 - 2026)

Twist Bioscience (TWST) has reported Assets Average for 9 consecutive years, with $657.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Assets Average rose 9.14% year-over-year to $657.1 million; the TTM figure through Mar 2026 stood at $657.1 million (up 9.14% YoY), while the FY2025 annual figure was $628.1 million, down 9.67% from the prior year.
• Assets Average climbed to $657.1 million in Q1 2026 per TWST's latest filing, from $640.0 million in the prior quarter.
• Across five years, Assets Average topped out at $1.0 billion in Q2 2022 and bottomed at $602.1 million in Q1 2025.
• Historically, Assets Average has averaged $756.5 million across 5 years, with a median of $717.8 million in 2024.
• Annual changes were most pronounced in 2022 — Assets Average jumped 42.69% — and 2024, when it slipped 21.07%.
• Twist Bioscience's Assets Average stood at $935.7 million in 2022, then fell by 19.35% to $754.6 million in 2023, then declined by 18.97% to $611.5 million in 2024, then gained by 4.66% to $640.0 million in 2025, then advanced by 2.68% to $657.1 million in 2026.
• Business Quant data shows TWST's Assets Average at $657.1 million in Q1 2026, $640.0 million in Q4 2025, and $642.7 million in Q3 2025.